Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ANIX

Anixa Biosciences (ANIX)

Anixa Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANIX
DateTimeSourceHeadlineSymbolCompany
14/02/202523:00PR Newswire (US)Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading InterviewNASDAQ:ANIXAnixa Biosciences Inc
12/02/202500:30PR Newswire (US)Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO ForumNASDAQ:ANIXAnixa Biosciences Inc
05/02/202500:30PR Newswire (US)Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer PreventionNASDAQ:ANIXAnixa Biosciences Inc
30/01/202502:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
28/01/202501:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
22/01/202500:30PR Newswire (US)Anixa Biosciences CEO Provides Letter to ShareholdersNASDAQ:ANIXAnixa Biosciences Inc
11/01/202509:25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIXAnixa Biosciences Inc
11/01/202509:18Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIXAnixa Biosciences Inc
04/01/202510:26Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ANIXAnixa Biosciences Inc
04/01/202509:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
04/01/202509:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
04/01/202509:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
04/01/202509:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
04/01/202509:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
05/12/202400:30PR Newswire (US)Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10NASDAQ:ANIXAnixa Biosciences Inc
23/11/202400:15PR Newswire (US)Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve AssetNASDAQ:ANIXAnixa Biosciences Inc
19/11/202400:20PR Newswire (US)Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
09/11/202405:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
09/11/202405:17PR Newswire (US)Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:ANIXAnixa Biosciences Inc
07/11/202400:30PR Newswire (US)Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:ANIXAnixa Biosciences Inc
31/10/202423:15PR Newswire (US)Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024NASDAQ:ANIXAnixa Biosciences Inc
28/10/202423:30PR Newswire (US)Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:ANIXAnixa Biosciences Inc
24/10/202402:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
16/10/202400:00PR Newswire (US)Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
07/10/202423:30PR Newswire (US)Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical DevelopmentNASDAQ:ANIXAnixa Biosciences Inc
30/09/202422:30PR Newswire (US)Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T TrialNASDAQ:ANIXAnixa Biosciences Inc
24/09/202422:30PR Newswire (US)Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
18/09/202422:30PR Newswire (US)Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer ConferenceNASDAQ:ANIXAnixa Biosciences Inc
07/09/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIXAnixa Biosciences Inc
03/09/202422:30PR Newswire (US)Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research SymposiumNASDAQ:ANIXAnixa Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ANIX